Replies to post #22605 on BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

Gold,
Look at what you just said,"what we do not need is a test that finds prostate cancer better"

30,000 people die every year in the USA from prostate cancer.

[TheBocx]

Nonsense! If you leave cancer alone, it will kill most patients, which is what happened 50 years ago. A diagnosis of cancer was practically a death sentence.

Here is a paper from 1956 from the Department of Surgery, University of Illinois College of Medicine stating that the rate of spontaneous regression is 1 in 80,000 to 1 in 100,000 patients...

http://www.pubmedcentral.nih.gov/pagerender.fcgi?artid=1465423&pageindex=1

Another thing you miss is that the pathology can tell if a cancer is aggressive or not and therefore all you risk is a biopsy procedure, not a surgical intervention with the risk of not waking up.

And even if all doctors were idiots and patients had to go through unnecessary surgery all the time, the risk of dying from the surgery is way lower than the risk of dying of cancer once it is diagnosed. Yes, there are exceptions, such as prostate cancer in the elderly and those particular cases have to be taken into consideration. Yet, even in those cases, the patient is monitored with PSA so that the doctor can react to any sudden increase of the marker.

In most other cancers, it is better to diagnose cancer AND treat it as soon as possible. This is supported by the medical establishment at large.

If there is a cancer marker to monitor the patient, much better, and if the marker is universal, and therefore it can be used in most cancers, which means lower cost (economies of scale) and in many cancers which cannot be detected by any other marker, even better. This is supported by common sense.